Mechanisms of action of mycophenolate mofetil in preventing acute and chronic allograft rejection.
about
In Vitro Influence of Mycophenolic Acid on Selected Parameters of Stimulated Peripheral Canine LymphocytesProspective, systematically recorded mycophenolate safety data in Graves' orbitopathy.Alpha-1,2-mannosidase and hence N-glycosylation are required for regulatory T cell migration and allograft tolerance in mice.Mycophenolate Mofetil and Pulmonary Fibrosis After Kidney Transplantation: A Case Report.Mycophenolate mofetil: effects on cellular immune subsets, infectious complications, and antimicrobial activityDepletion of the programmed death-1 receptor completely reverses established clonal anergy in CD4(+) T lymphocytes via an interleukin-2-dependent mechanism.Antiproliferative effects of AVN944, a novel inosine 5-monophosphate dehydrogenase inhibitor, in prostate cancer cellsEffects of mycophenolate mofetil on proliferation and mucin-5AC expression in human conjunctival goblet cells in vitroMycophenolic acid differentially impacts B cell function depending on the stage of differentiation.Ribosomal proteins: functions beyond the ribosomeMycophenolic acid activation of p53 requires ribosomal proteins L5 and L11Mycophenolate mofetil for myasthenia gravis: a clear and present controversyMycophenolate mofetil: safety and efficacy in the prophylaxis of acute kidney transplantation rejection.An inosine 5'-monophosphate dehydrogenase 2 single-nucleotide polymorphism impairs the effect of mycophenolic acid.Mycophenolic acid inhibits migration and invasion of gastric cancer cells via multiple molecular pathways.Immune profiling and cancer post transplantationMycophenolic acid response biomarkers: a cell line model system-based genome-wide screen.Sirolimus and mycophenolate mofetil as GVHD prophylaxis in myeloablative, matched-related donor hematopoietic cell transplantationRegulation of ribosomal RNA synthesis in T cells: requirement for GTP and Ebp1.Endoscopic and histological features of mycophenolate mofetil colitis in patients after solid organ transplantation.EBV-associated lymphoproliferative disorder of CNS associated with the use of mycophenolate mofetilAntibody-mediated rejection: an evolving entity in heart transplantation.Pure red cell aplasia associated with type I autoimmune polyglandular syndrome-successful response to treatment with mycophenolate mofetil: case report and review of literature.Effect and safety of mycophenolate mofetil or sodium in systemic sclerosis-associated interstitial lung disease: a meta-analysisTargeted inhibition of glucuronidation markedly improves drug efficacy in mice - a model.Population pharmacokinetics of mycophenolic acid and dose optimization with limited sampling strategy in liver transplant children.Effects of unbound mycophenolic acid on inosine monophosphate dehydrogenase inhibition in pediatric kidney transplant patients.Drug-induced immunomodulation to affect the development and progression of atherosclerosis: a new opportunity?Mycophenolate mofetil and atherosclerosis: results of animal and human studies.A Unique Case of Mycophenolate Induced Colitis after 10 Years of Use.Immunologic unresponsiveness to alloantigen in vivo: a role for regulatory T cells.Strategies to prevent or reduce acute and chronic kidney injury in liver transplantation.Drug-induced inflammatory bowel disease and IBD-like conditions.Clinical pharmacokinetics and pharmacodynamics of mycophenolate in patients with autoimmune disease.PharmGKB summary: mycophenolic acid pathway.Therapeutic drug monitoring in pediatric renal transplantation.Pharmacology and toxicology of mycophenolate in organ transplant recipients: an update.Does the nature of residual immune function explain the differential risk of non-melanoma skin cancer development in immunosuppressed organ transplant recipients?Mycophenolate mofetil for lupus nephritis: an update.Population pharmacokinetics and Bayesian estimation of mycophenolic acid concentrations in Chinese adult renal transplant recipients.
P2860
Q28551762-A1B78A4A-69E8-4CFE-97C7-6C22F43C14EBQ31047067-CB67F87D-136E-4F10-AEBF-B0D923B24AD1Q33529115-C56EC1CE-3F9E-477C-AA8D-76ADF630444AQ33583604-1E7E5550-D508-4D5F-94A0-AC07EC146025Q33781206-2F228F4E-BD4A-4EEA-83BF-E5ACC3187380Q33877649-C6A7673D-3B21-4539-B6E7-5F3624301605Q33921228-664D8822-EC40-4E0E-B8D9-FE21337755A6Q34208099-48919B8C-1636-4C52-BB50-9D7D53AC030BQ34267100-2F59EACA-EDE9-425F-ABFF-74D28EA8042EQ34465473-B904294C-8770-4B36-9358-107A5AB1BAE1Q34588852-3E965F26-879F-4D4D-94AE-7EE03F0367CDQ34606062-D7A9B1ED-6453-4907-B714-65EF415BD189Q34607590-267F97CA-98F9-4412-908D-FDB293B3798CQ35004404-A7CE34C7-C7E5-4977-B50C-45B61589AC99Q35049578-470AB858-0583-432B-894B-34B33386C0D3Q35050810-439F0684-F4D5-4B0F-9E65-461A98354ED7Q35112606-DA134A0F-1A32-4CEA-B109-8C07A483B061Q35184589-BBB0204F-8AC6-4D3D-9CD9-550BFB0CD6E3Q35450533-D93FD8A0-457B-4AF7-ADA0-8ABED46B2A26Q35779482-26FE34E5-7E9F-4E58-9056-005C4B12CA17Q35870511-0CACD840-4688-47DD-98CC-39F8C16C3F6DQ35876250-D02D72F0-3790-428D-A4BA-3EA70FB3F23FQ35954307-4C5A415D-B273-4D4D-8164-7A05A87870E4Q35977704-A7C9FE61-52BA-4812-8803-3CF7A3067AEFQ36083034-B86A852A-F0F1-47FB-BB1E-FFDD7539E3DFQ36336060-23F49BCE-B9D6-49BD-80BC-D26F4AE1986DQ36393014-C08BACFA-5AB2-46AF-A6FF-581455647327Q36752124-2AA56BB1-0077-4E9D-A390-AA97DC8437B5Q36958317-6B2201F6-BEED-48E4-BFD5-AD838FF282A8Q37271090-A9B77312-C165-4BAA-9D3E-511A9E807C3AQ37864694-2BCDE7B1-4D53-4688-B138-6A96D3087C87Q37899942-893B0A04-60C8-4605-BD6C-CA08B146BACBQ38008983-8EFE156C-900B-4FFC-8FB8-F7BA13F6A09DQ38087925-B8DECF8E-DEC9-4822-BADC-4D102F7C6804Q38162034-8656E4A1-011E-41B4-A8CC-ECA2CC20F462Q38206952-F4AC8EC2-329F-4899-8039-EDD01CBE7A74Q38208983-5ABFF3D9-A820-44A5-96D6-F55979E76791Q38328785-0D80E2C7-1CB1-4FE1-9D00-29E33160B0EEQ38585887-7217EACD-DE0E-462D-90E0-87E62351EA9AQ38610665-9DF79311-EE33-44B6-9A51-A2DE6831807C
P2860
Mechanisms of action of mycophenolate mofetil in preventing acute and chronic allograft rejection.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Mechanisms of action of mycoph ...... d chronic allograft rejection.
@ast
Mechanisms of action of mycoph ...... d chronic allograft rejection.
@en
type
label
Mechanisms of action of mycoph ...... d chronic allograft rejection.
@ast
Mechanisms of action of mycoph ...... d chronic allograft rejection.
@en
prefLabel
Mechanisms of action of mycoph ...... d chronic allograft rejection.
@ast
Mechanisms of action of mycoph ...... d chronic allograft rejection.
@en
P1433
P1476
Mechanisms of action of mycoph ...... d chronic allograft rejection.
@en
P2093
Anthony C Allison
Elsie M Eugui
P304
P356
10.1097/01.TP.0000186390.10150.66
P433
P577
2005-10-01T00:00:00Z